New research: Incidence of side effects in patients receiving rTMS

Our Bristol based Practitioner, Harpreet Singh (known as Vinny), with support from our Medical Director Dr Leigh Neal, has produced an academic poster for the Clinical TMS Society’s virtual poster session 2020 looking at the incidence of side effects in patients receiving repetitive transcranial magnetic stimulation (rTMS).

Harpreet TMS

The results are based on 115 daily logs from Smart TMS patients treated between 2015 and 2019. Ages ranged from 18-85 and patients were treated across 7 different Smart TMS clinics.

Headaches, fatigue and scalp discomfort were identified as the most common side effects at 20%, 16.5% and 6% respectively. Other side effects were seen at much lower rates. The findings aim to inform clinicians and other healthcare providers about the relative safety of TMS.

At Smart TMS, we are committed to driving standards of TMS treatment in the UK. Dr Leigh Neal as our Medical Director is actively involved in driving these standards and also participates in research studies for the use of TMS for different conditions.

See our recent blog on TMS for the treatment of cocaine addiction study here.